pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

30,645 catalysts · 11,000 approval · 5,000 device 510k · 4,728 grant · 3,126 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2015-10-28×clear all
type
  • approval11,000
  • device 510k5,000
  • grant4,728
  • 8k filing3,126
  • device pma2,000
  • device recall2,000
recall
1,126
  • device adverse event1,000
  • earnings583
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 11, 2016

    14
    ›Jan 12, 2016approval3865d agoULTIVA (REMIFENTANIL HYDROCHLORIDE) — FDA approvalremifentanil hydrochloride

    Sponsor: MYLAN INSTITUTIONAL. Form: INJECTABLE. Route: INJECTION

    full page →remifentanil hydrochloride →fda approvals ↗
    ›Jan 12, 2016approval3865d agoJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →SYNJARDY →fda approvals ↗
    ›Jan 12, 2016approval3865d agoVORICONAZOLE — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 12, 2016approval3865d agoVORICONAZOLE — FDA approvalMylan Pharmaceuticals Inc

    Sponsor: MYLAN PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 13, 2016approval3864d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Jan 13, 2016approval3864d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Jan 13, 2016approval3864d agoLOPROX (CICLOPIROX) — FDA approvalATLAS Molecular Pharma SL

    Sponsor: EUROFARMA. Form: CREAM. Route: TOPICAL

    full page →fda approvals ↗
    ›Jan 15, 2016approval3862d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 15, 2016approval3862d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 15, 2016approval3862d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

    Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 15, 2016approval3862d agoABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalaripiprazole LA

    Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →aripiprazole LA →fda approvals ↗
    ›Jan 15, 2016approval3862d agoCLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: GEL. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Jan 15, 2016approval3862d agoCLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: SWAB. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗
    ›Jan 15, 2016approval3862d agoCLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: LOTION. Route: TOPICAL

    full page →CLEOCIN →fda approvals ↗

    Week of Jan 18, 2016

    26
    ›Jan 19, 2016approval3858d agoKESIMPTA (OFATUMUMAB) — FDA approvalKESIMPTA

    Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →KESIMPTA →fda approvals ↗
    ›Jan 19, 2016approval

    Week of Jan 25, 2016

    8
    ›Jan 26, 2016approval3851d agoDUOPA (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL

    full page →carbidopa →fda approvals ↗
    ›Jan 26, 2016approval

    Week of Feb 1, 2016

    2
    ›Feb 1, 2016approval3845d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

    Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 3, 2016approval
    ← prev
    page 4 of 613
    next →
    3858d ago
    VIVITROL (NALTREXONE) — FDA approvalnaltrexone ER

    Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

    full page →naltrexone ER →fda approvals ↗
    ›Jan 19, 2016approval3858d agoQOLIANA (BRIMONIDINE TARTRATE) — FDA approvalLumify

    Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Lumify →fda approvals ↗
    ›Jan 19, 2016approval3858d agoLACTATED RINGER'S AND DEXTROSE 5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE) — FDA approvalCALCIUM CHLORIDE 10%

    Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →CALCIUM CHLORIDE 10% →fda approvals ↗
    ›Jan 21, 2016approval3856d agoCLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalclindamycin hydrochloride

    Sponsor: PFIZER. Form: CAPSULE. Route: ORAL

    full page →clindamycin hydrochloride →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETOPROLOL TARTRATE — FDA approvalIpca Pharmaceuticals Inc

    Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETOPROLOL TARTRATE — FDA approvalIpca Pharmaceuticals Inc

    Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMEFENAMIC ACID — FDA approvalMEFENAMIC ACID

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →MEFENAMIC ACID →fda approvals ↗
    ›Jan 21, 2016approval3856d agoJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

    full page →SYNJARDY →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 21, 2016approval3856d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Jan 22, 2016approval3855d agoISOVUE-370 (IOPAMIDOL) — FDA approval

    Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 23, 2016approval3854d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

    Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

    full page →nivolumab →fda approvals ↗
    3851d ago
    BINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Jan 26, 2016approval3851d agoDEFERASIROX — FDA approvalDEFERASIROX

    Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →DEFERASIROX →fda approvals ↗
    ›Jan 27, 2016approval3850d agoMILNACIPRAN HYDROCHLORIDE — FDA approvalMILNACIPRAN HYDROCHLORIDE

    Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL

    full page →MILNACIPRAN HYDROCHLORIDE →fda approvals ↗
    ›Jan 27, 2016approval3850d agoNORGESTIMATE AND ETHINYL ESTRADIOL (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: MYLAN. Form: TABLET. Route: ORAL-28

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Jan 27, 2016approval3850d agoADZENYS XR-ODT (AMPHETAMINE) — FDA approvalTraws Pharma, Inc.

    Sponsor: NEOS THERAPS. Form: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 29, 2016approval3848d agoSTALEVO 75 (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Jan 29, 2016approval3848d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalIGC Pharma, Inc.

    Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL

    full page →fda approvals ↗
    3843d ago
    CIMZIA (CERTOLIZUMAB PEGOL) — FDA approvalcertolizumab pegol

    Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION

    full page →certolizumab pegol →fda approvals ↗
    $PFE26.63-1.57%
    $NVS155.21-1.01%
    $PFE26.63-1.57%
    $NVS155.21-1.01%
    $ABBV249.50+0.61%
    $NVS155.21-1.01%
    $PFE26.63-1.57%
    $PFE26.63-1.57%
    $ALKS49.21-0.38%
    $BMY63.75-1.68%
    $TRAW
    $OGN13.65+0.22%
    $IGC0.2670+0.41%
    $ORN12.42-2.13%